Explore RKLB stock price, technical analysis, earnings, analyst ratings, and forecast. Is RKLB stock a buy? Get balanced insights on Rocket Lab USA for investors.
Introduction
Rocket Lab USA builds rockets and spacecraft. It launches small satellites with Electron rockets and develops the Neutron medium-lift rocket. RKLB stock draws attention due to strong revenue growth and space industry demand.
Investors watch RKLB stock now for its record backlog and Neutron progress. Broader market conditions favor tech stocks amid defense spending rises. Yet delays in launches add caution.
Latest Stock Price & Trend
RKLB stock closed at $69.10 on February 27, 2026, down 4.89% for the day from $72.65. The 1-day drop followed Neutron delay news. Over five days, it fell amid profit-taking after highs near $70.
In the past month, RKLB stock price gained amid earnings beats. Three-month trend shows strength from Q4 results. Year-to-date through late February, shares surged over 100% from 2025 lows around $39, hitting 52-week high of $99.58 and low of $14.71.
Six-month trend remains bullish with revenue catalysts. Overall direction leans bullish but pulled back recently. This signals momentum for growth investors, though volatility warns of risks.
Technical Analysis
Support levels sit at $64.09, a key floor from recent lows. Resistance stands at $78.19; breaking it could push higher. RSI at 44.6 shows neutral, not overbought or oversold—room for moves without extremes.
MACD at -1.94 gives a sell signal short-term, hinting at cooling momentum. The 50-day moving average tops the 200-day at about $72.73 vs $52.90, a bullish golden cross setup.
Volume trends up lately, averaging 23.8 million shares vs 25.7 million on the close day. Higher volume backs trends, aiding reliability for beginners tracking momentum.
Analyst Ratings & Price Targets
Of 21 analysts, 10 rate Buy, 5 Hold, 0 Sell—bullish consensus. Average price target hits $82.78, with high $120 and low $55.
Recent upgrades include BofA raising to $120 (Strong Buy) on January 20, 2026, and Morgan Stanley to Buy at $105. Roth Capital lifted to $90 from $75. This sentiment points to upside for RKLB stock, driven by backlog and growth, but targets vary on execution risks.
Insider Activity
Insiders sold recently, like Jon Olson dumping over 8,000 shares at $89-$90 on January 20, 2026. Matthew Ocko sold large blocks worth millions in September 2025 at $50+.
No major buys noted in last six months; trend shows sales amid stock rise. This may signal caution or personal needs, not panic—watch for confidence shifts in management holdings.
Valuation Analysis
Trailing P/E stands negative at -181.84 due to losses; forward P/E reflects profitability hopes. Price-to-sales ratio suits high-growth space firm at premium levels.
Revenue grew 36% YoY to $180 million in Q4 2025; full-year $602 million up 38%. EPS loss narrowed to -$0.09; free cash flow burns cash at -$100 million+ quarterly from capex. Debt low at $154 million long-term, cash strong at $1.02 billion Q4 end.
Vs peers like SpaceX privates or Airbus, RKLB appears fairly valued for growth but stretched if delays persist. Not undervalued yet, watch margins.
Recent Earnings & Catalysts
Q4 2025 revenue hit $179.7 million vs $176.8 million expected; EPS -$0.10 missed -$0.05 slightly. Full-year backlog reached $1.85 billion, up 73%, with $816 million SDA contract.
Guidance: Q1 2026 revenue $185-200 million, EBITDA loss $21-27 million. Catalysts include Neutron to Q4 2026 despite tank delay, Geost acquisition for payloads, 21 launches in 2025. Earnings boosted stock initially but delay caused pullback.
Bullish Case
Revenue growth hits 38% in 2025, backlog $1.85 billion fuels pipeline. Space systems dominate at 74% mix with high margins.
Neutron enters medium-lift market, NSSL program access $5.6 billion. Vertical integration via acquisitions cuts costs long-term.
Bearish Case
Neutron delay to late 2026 from tank failure raises execution risks. Losses persist: Q4 net -$52.9 million, EBITDA negative.
Competition from SpaceX intense; capex burns cash amid high valuation. Regulatory shifts in defense spending could slow contracts.
Market Sentiment
Short interest at 57.8 million shares, down 4%, days-to-cover 2.5—low, positive sign. Institutional ownership strong: Vanguard 47 million shares, BlackRock 33 million.
Options show balanced calls/puts; retail optimistic on forums. Sentiment neutral to optimistic, momentum bias over value.
Short-Term Outlook
Technicals show pullback with MACD sell, RSI neutral. Volume steady, market momentum cools post-earnings.
Expect sideways to mild dip near support $64 in coming weeks. Watch volume for rebound clues.
Medium to Long-Term Outlook
Business model scales via Electron cadence and Neutron reusability. Industry grows 10%+ annually on satellite demand.
Financial health solid with $1.1 billion cash; competitive edge in small launches. Long-term: Hold or accumulate on dips for growth investors.
FAQ
Is RKLB stock a buy? Analysts lean Buy with $83 median target, but risks from delays suggest watch for entry.
RKLB stock price target? Average $68-83, high $120 from recent upgrades.
RKLB earnings next? Q1 2026 revenue $185-200M expected; track Neutron updates.
Major risks for RKLB stock? Launch delays, cash burn, SpaceX rivalry.
RKLB forecast 2026? Revenue $843M projected, path to breakeven.
Suggestions
Compare with Opendoor stock.
See Boeing stock analysis for aerospace peers.
Read space sector valuation trends.
Final Balanced Conclusion
Hold RKLB stock. Growth from backlog and launches offsets delay risks; valuation fits if execution holds. Watch Q1 earnings.
Disclaimer: This article is for informational purposes only and not financial advice.